iGMDRD123


Canonical SMILES: CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3

InChI: InChI=1S/C19H17N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,18,20H,10-11H2,1H3

InChI Key: TXDUTHBFYKGSAH-UHFFFAOYSA-N

Loading, please wait...
Standard Name
Pubchem CID
Drug Status
Drug Type
Standard NameIsoevodiamine
Pubchem CID151289
Drug StatusAlone
Drug TypeSmall Molecule

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
331 XIAP 2
3696 ITGB8 3
64901 RANBP17 1
1105 CHD1 2
Showing 1 to 4 of 578 rows rows per page

Gene in drug-gene network: Network Plot

SN-38SN-38MST-312MST-312tipifarnib-P2tipifarnib-P2navitoclaxnavitoclaxparbendazoleparbendazoleABT737ABT737FedratinibFedratinibNSC141540NSC141540piperlonguminepiperlonguminepevonedistatpevonedistatindisulamindisulamFqi1Fqi1FQI-2FQI-2CHM-1CHM-1KIAA1549KIAA1549RITARITABX-795BX-795BMS-536924BMS-536924cytochalasin.Bcytochalasin.BBI-2536BI-2536Compound.1541ACompound.1541ACyanoquinoline, 11Cyanoquinoline, 11TGX-115TGX-115leucascandrolide Aleucascandrolide ALY 2183240LY 2183240VX-680VX-680oligomycin.Aoligomycin.A179324-69-7179324-69-7SCHEMBL2608041SCHEMBL2608041nutlin 3nutlin 3SirolimusSirolimus4-methylfasudil4-methylfasudilHIPK3HIPK3PP-30PP-30BMS-754807BMS-754807quinoclaminequinoclamineBRD4132BRD4132GMX1778GMX1778(-)-gallocatechin-3-O-gallate(-)-gallocatechin-3-O-gallate17-AAG17-AAGTBK1TBK1manumycin.Amanumycin.ASR-II-138ASR-II-138ANSC23766NSC23766EXT1EXT1QuiflaponQuiflaponDactolisibDactolisibABT-751ABT-751CHEMBL1434137CHEMBL1434137tamatinibtamatinibCDH2CDH2ELCPKELCPKCompound 44Compound 44ISX-9ISX-9BIX01294BIX01294Compound.7d.cisCompound.7d.cisSB225002SB225002austocystin.Daustocystin.DnakiterpiosinnakiterpiosinBRD4770BRD4770MK-2206MK-2206batimastatbatimastatPAC-1PAC-1GRK6GRK6CHEMBL399379CHEMBL399379GW-843682XGW-843682XNVP-AUY922NVP-AUY922triptolidetriptolideSDHBSDHBPI-103PI-103CIL55ACIL55ABRD6368BRD6368Nsc 632839Nsc 632839ML214ML214Compound.23.citrateCompound.23.citrateBax.channel.blockerBax.channel.blockerLMO1LMO1PX 12PX 12IdarubicinIdarubicinFK 866FK 866ParthenolideParthenolide2,4-dideoxy-DC-45-A22,4-dideoxy-DC-45-A2YK.4.279YK.4.279chaetocinchaetocinzebularinezebularinePRIMA-1METPRIMA-1METAXLAXLtriacsin Ctriacsin Cruxolitinib (in SH2B3 deleted)ruxolitinib (in SH2B3 deleted)pluripotinpluripotinJAK2JAK2rotenonerotenoneTW-37TW-37TEX14TEX14selumetinib in BRAF mutant tumorsselumetinib in BRAF mutant tumorsimportazoleimportazoleBRD9876BRD9876BRD7137BRD7137PF750PF750ACVRL1ACVRL1kinetin ribosidekinetin ribosideNeratinibNeratinibGATA2GATA2salermidesalermideursolic acidursolic acidSGK1SGK1SepantroniumSepantroniumNR1H3NR1H3VER 155008VER 155008ubistatin Bubistatin BgossypolgossypolPemetrexedPemetrexedMPLMPLNSC95397NSC95397ML162ML162Merck60Merck60NPC26NPC26SERPINA12SERPINA12curcumincurcuminWNK3WNK3GemcitabineGemcitabineEPHA4EPHA4brefeldin.Abrefeldin.AserdemetanserdemetanLRRC2LRRC2tanespimycintanespimycinteniposideteniposideIGFBP5IGFBP5CDK4/6 inhibitorsCDK4/6 inhibitorsBRD63610BRD63610PD-0332991PD-0332991PRIMA-1PRIMA-1UNC0638UNC0638lovastatin acidlovastatin acidavrainvillamideavrainvillamideCIL41CIL41erastinerastinCCND1CCND1AZD-1775AZD-1775DLC1DLC1PNU-74654PNU-74654MAPKAPK2MAPKAPK2TNIKTNIKCompound 110Compound 110SMG1SMG1MST1RMST1RneopeltolideneopeltolideML 210ML 210tivozanibtivozanibitraconazoleitraconazolebistramide Abistramide AVorinostat (SAHA)Vorinostat (SAHA)ChloropentafluorobenzeneChloropentafluorobenzeneKAT6AKAT6AATP10AATP10ATCF12TCF12penfluridolpenfluridolAACOCF3AACOCF3AM-580AM-580CYFIP1CYFIP1CHIR-99021CHIR-99021SCH-529074SCH-529074DC-45-A2DC-45-A2PABPN1PABPN1GW-405833GW-405833N9-Isopropyl-olomoucineN9-Isopropyl-olomoucineCompound 10b [PMID: 11504634]Compound 10b [PMID: 11504634]SOX10SOX10dexamethasonedexamethasoneEIF4A1EIF4A1ABCC3ABCC3SKI IISKI IIPTPRTPTPRTPRL-3 Inhibitor IPRL-3 Inhibitor IOSW-1OSW-1JQ1 CompoundJQ1 CompoundLRIF1LRIF1(1S,3R)-RSL3(1S,3R)-RSL3NLKNLKSIX4SIX4BCKDKBCKDKRIOK3RIOK3Fatostatin AFatostatin APIK-75PIK-75TRIP11TRIP11SACSSACSMAP3K9MAP3K9TIE1TIE1ADAM17ADAM17NSD2NSD2ADAMTS18ADAMTS18ciclosporinciclosporinCD437CD437SLC29A1SLC29A1kahalalide Fkahalalide FITGA10ITGA10LexibulinLexibulinPDCD1PDCD1GRIK1GRIK1MDM2/MDMX inhibitorsMDM2/MDMX inhibitorsRB1RB1ceruleninceruleninKDRKDRLE-135LE-135ML006ML006CDC7CDC7TRIM42TRIM42PD-0325901PD-0325901PYGBPYGBsparfosic acidsparfosic acidNEK3NEK3BML-259BML-259WASWASTyrphostin AG 1478Tyrphostin AG 1478UNC79UNC79E2F1E2F1pifithrin-mupifithrin-muBMPR1ABMPR1APPARGC1APPARGC1ACSPG4CSPG4MAP4K3MAP4K3TBX18TBX18IRAK2IRAK2RANBP9RANBP9IL1AIL1AADGRG4ADGRG4MCF2MCF2TTLTTLMAP3K5MAP3K5PRPF4BPRPF4BRo 28-1675Ro 28-1675PIK3C3PIK3C3TamoxifenTamoxifenvaldecoxibvaldecoxibSMR000068650SMR000068650BRD1812BRD1812SIK2SIK2tensirolimus plus chemotherapytensirolimus plus chemotherapySCHEMBL13586708SCHEMBL13586708EverolimusEverolimusMTORMTORSNX19SNX19NIPBLNIPBLURB2URB2CHD9CHD9CGP-082996CGP-082996CDK3CDK3CYLDCYLDCDKN2BCDKN2Bpyrvinium pamoatepyrvinium pamoateOSI-906 (Linsitinib)OSI-906 (Linsitinib)PK-11195PK-11195fumonisin.B1fumonisin.B1MCL1MCL1CHEK2CHEK2BicalutamideBicalutamideEnzalutamideEnzalutamideARN-509ARN-509AndrogenAndrogenFlutamideFlutamideabirateroneabirateroneAREGAREGNSC74859NSC74859LMO2LMO2KCNH2KCNH2HDAC1HDAC1RPS6KC1RPS6KC1IL1R1IL1R1TRPS1TRPS1purmorphaminepurmorphamineRALGDSRALGDSNSD3NSD3BRD4354BRD4354OlaparibOlaparibJAZF1JAZF1CRTC1CRTC1HDAC2HDAC2NEK9NEK9ADAM32ADAM32VAV1VAV1TCEA1TCEA1TNFRSF11BTNFRSF11BMECOMMECOMMOCOSMOCOSPD0325901PD0325901LMNALMNAHECW1HECW1BAG6BAG6STK10STK10CDK2/4 inhibitorsCDK2/4 inhibitorsVNLG/124VNLG/124CDKN1BCDKN1BCTSLCTSL3-chloro-L-alanine3-chloro-L-alanineWRNWRNsimvastatinsimvastatinDCLK1DCLK1GSK3BGSK3BEPHA3EPHA3tosedostattosedostatDYRK3DYRK3STARSTARMYO18BMYO18BNTRK1NTRK1OR4E2OR4E2all trans Retinoic Acidall trans Retinoic AcidALPK1ALPK1PPP1R3APPP1R3ACARSCARSMN1MN1CCNG1CCNG1PHKG1PHKG1MAP4K5MAP4K5CAY10618CAY10618HSCI1_000270HSCI1_000270docetaxel in KRAS mutantdocetaxel in KRAS mutantNVP-231NVP-231SB-743921SB-743921daporinaddaporinadDPP4DPP4IFNGIFNGDCLK2DCLK2Mytomycin CMytomycin CCHD1CHD1CTSVCTSVGRIA3GRIA3PPP3CBPPP3CBPDMPPDMPFBXW7FBXW7RASGRF1RASGRF1GCNT2GCNT2TAL1TAL1AXIN1AXIN1CASP10CASP10AKAP9AKAP9CLTCL1CLTCL1VRK2VRK2blebbistatinblebbistatinNUP153NUP153MSH6MSH6PCM1PCM1ADAM10ADAM10ALPK3ALPK3WDHD1WDHD1SHC1SHC1LTKLTKBMP2KBMP2KSOX2SOX2OnalespibOnalespibBCL6BCL6TNFRSF9TNFRSF9AFDNAFDNLetrozoleLetrozoleCTNNB1CTNNB1IRS1IRS1TECTECTGFB1TGFB1MLH1MLH1KU0060648KU0060648PDE4DIPPDE4DIPELLELLLDN 193189LDN 193189BUB1BUB1TLK1TLK1CSMD3CSMD3mTOR inhibitorsmTOR inhibitorsTSC2TSC2CDH15CDH15ABI1ABI1CAMK1CAMK1LRP2LRP2AKAP6AKAP6TRPM8TRPM8TOP2ATOP2APAX3PAX3PIP4K2BPIP4K2BTTBK2TTBK2CSF1RCSF1RFYNFYNCNTRLCNTRLTCF7L1TCF7L1MAP2K4MAP2K4IPA-3IPA-3BLNKBLNKSULF1SULF1DDX10DDX10P2RX7P2RX7CHN1CHN1PDCD11PDCD11CAMKK2CAMKK2ERLIN2ERLIN2NANOS3NANOS3PCDH15PCDH15FGFR1OPFGFR1OPcetuximabcetuximabPI3K pathway inhibitors (alone or in combination)PI3K pathway inhibitors (alone or in combination)PI3K pathway inhibitorsPI3K pathway inhibitorsBYL719 (Alpelisib)BYL719 (Alpelisib)trastuzumab alonetrastuzumab alonePIK3CAPIK3CATNK2TNK2TFEBTFEBPAXIP1PAXIP1PRCCPRCCMAP4K2MAP4K2CACNB2CACNB2ALPK2ALPK2OLIG2OLIG2NUP98NUP98NR2F1NR2F1SH3GL1SH3GL1TEKTEKERCC3ERCC3RBL2RBL2ITPR2ITPR2BLKBLKARHGEF10ARHGEF10MTMR11MTMR11MCM4MCM4HDAC6HDAC6HSPB1HSPB1CDC42BPBCDC42BPBKDM5AKDM5ATLE1TLE1FAM118AFAM118AMYO3BMYO3BMALT1MALT1ATICATICAC55649AC55649TOXTOXMTCL1MTCL1BICRABICRALYNLYNWNK4WNK4FRKFRKSTK40STK40EIF4EBP1EIF4EBP1ITGB8ITGB8NYNRINNYNRINNCOA3NCOA3LATS1LATS1PRAMEPRAMEBRIP1BRIP1B02B02ING1ING1ARHGAP26ARHGAP26CLASP1CLASP1POU5F1BPOU5F1Blapatinib in HER2-amplifiedlapatinib in HER2-amplifiedERBB4ERBB4LAMP1LAMP1PARP inhibitorsPARP inhibitorsEZH2 inhibitorEZH2 inhibitorHDAC inhibitorsHDAC inhibitorsMAGI1MAGI1IL1RAPIL1RAPIRAK3IRAK3SUFUSUFUF8F8TPH1TPH1ASTN1ASTN1BTRCBTRCCLTCCLTCLATS2LATS2STAT6STAT6STRADBSTRADBULK3ULK3GLI2GLI2EIF3AEIF3ARPS6KA6RPS6KA6MRE11MRE11L-685458L-685458CCNT1CCNT1CHRNB4CHRNB4AKT3AKT3RibociclibRibociclibCDK4CDK4PIP4K2CPIP4K2CPBX1PBX1MMP2MMP2PLCG2PLCG2DSTDSTPEAK1PEAK1BRD8958BRD8958ITGB4ITGB4RORARORATSSK1BTSSK1BLAMA1LAMA1PDK3PDK3STK38LSTK38LRHOARHOAPRKD3PRKD3STRADASTRADAACOD1ACOD1PLAG1PLAG1NR4A3NR4A3BET inhibitorsBET inhibitorsMYCMYCPIK3R4PIK3R4DasatnibDasatnibCSF3RCSF3RBMPR1BBMPR1BTRRAPTRRAPEP300EP300MEK inhibitorsMEK inhibitorsERK inhibitorsERK inhibitorsBRAF inhibitorsBRAF inhibitorsDabrafenibDabrafenibMAP2K2MAP2K2XIAPXIAPPOU2AF1POU2AF1N4BP2N4BP2ZMYM2ZMYM2LIFRLIFRCDKL5CDKL5HOXD13HOXD13NTRK2NTRK2PaclitaxelPaclitaxelEDNRBEDNRBTESK2TESK2BCAR1BCAR1DHDDSDHDDSJARID2JARID2FANCAFANCACNTN6CNTN6FGF19FGF19SCARA5SCARA5GRK7GRK7SPEGSPEGTTNTTNCDKL2CDKL2YWHAHYWHAHEPHA5EPHA5BUB1BBUB1BPSIP1PSIP1GRK5GRK5MIA3MIA3IKBKBIKBKBPAX8PAX8NPATNPATINPP4BINPP4BARID1AARID1ATP63TP63NOTCH2NOTCH2MSH3MSH3P4HBP4HBTHRAP3THRAP3MAML3MAML3CLPTM1CLPTM1CDK13CDK13RPS6KL1RPS6KL1MAP3K4MAP3K4SRFSRFDEKDEKRGS22RGS22PDGFRBPDGFRBBRCC3BRCC3MAP2K3MAP2K3CDKN2ACDKN2AMAML2MAML2CDK12CDK12ADAM28ADAM28ACOXLACOXLCYP1B1CYP1B1PICALMPICALMDNAH8DNAH8RIPK4RIPK4ML203ML203CIL56CIL56MAP3K19MAP3K19MITFMITFZNF331ZNF331MUSKMUSKTLR3TLR3CTBP2CTBP2NEK6NEK6GSDMEGSDMEATRXATRXPIP5K1BPIP5K1BAMER1AMER1pifithrin-alphapifithrin-alphaADKADKDDR1DDR1TAOK1TAOK1CAMKVCAMKVCDC42BPACDC42BPARASA3RASA3IL17RDIL17RDIL3IL3EIF4G1EIF4G1ZBTB16ZBTB16ATP13A5ATP13A5HNF1BHNF1BEIF2AK3EIF2AK3SETDB1SETDB1CNTN1CNTN1VRK1VRK1SorafenibSorafenibSunitinibSunitinibNilotinibNilotinibPonatinibPonatinibHSP90 inhibitorsHSP90 inhibitorsImatinib MesylateImatinib MesylateRegorafenibRegorafenibKITKITSOS1SOS1PGRPGRPREX2PREX2LRGUKLRGUKFBXO43FBXO43SERPINA2SERPINA2ALS2ALS2ZNF497ZNF497PIK3R2PIK3R2TMEM74TMEM74GDNFGDNFCCDC170CCDC170PI4KAPI4KAADCK2ADCK2MAP3K1MAP3K1TPRTPRHSP90AB1HSP90AB1PTPRCPTPRCTBCKTBCKNutlin-3aNutlin-3aFH535FH535Y-39983Y-39983Bryostatin.1Bryostatin.1CASP1CASP1AZD-8055AZD-8055AZD6482.1AZD6482.1STF62247STF62247FOXP1FOXP1PHIPPHIPNPRL2NPRL2CEP-701CEP-701FLT1FLT1platinum agentsplatinum agentsRucaparibRucaparibchemotherapychemotherapyBRCA1BRCA1AfatnibAfatnibSMAD4SMAD4DFFADFFAPLK4PLK4AFF1AFF1PTPRUPTPRUPRKD1PRKD1TGTGNUDT10NUDT10UNC13CUNC13CRAG1RAG1RNASEH2ARNASEH2ARAP1GDS1RAP1GDS1HSP90B1HSP90B1IFNB1IFNB1CDK19CDK19CFICFIKMT2CKMT2CMED13LMED13LsaracatinibsaracatinibTELO2TELO2MYH9MYH9ITKITKRBM15RBM15TPOTPOCD160CD160IL6STIL6STPLEKHA5PLEKHA5PanitumumabPanitumumabPLX-4720PLX-4720VemurafenibVemurafenibBinimetinib (MEK162)Binimetinib (MEK162)RefametinibRefametinibTrametinibTrametinibNRASNRASPTPRDPTPRDTSC1TSC1CEBPACEBPATANKTANKFOXO3FOXO3HOXC11HOXC11MYH1MYH1SEMA5BSEMA5BSCYL2SCYL2AXIN2AXIN2CTNNA2CTNNA2BIRC6BIRC6PLK2PLK2PTCH2PTCH2NOTCH3NOTCH3PSEN2PSEN2FHITFHITMEN1MEN1Avagacestat (BMS-708163)Avagacestat (BMS-708163)IL1BIL1BKDM6AKDM6APIK3R1PIK3R1COQ8ACOQ8AC1DC1DTMPOTMPOTHBS3THBS3JAG1JAG1CREBBPCREBBPMAP3K7MAP3K7LIMK1LIMK1SERPINB1SERPINB1WEE1WEE1FNBP1FNBP1ROCK2ROCK2DGKBDGKBERCC6ERCC6RAD50RAD50FZD1FZD1STILSTILNAV3NAV3ICKICKCHEMBL258148CHEMBL258148ITPR1ITPR1JAK inhibitorsJAK inhibitorsCBLCBLHERC2HERC2TNRC6BTNRC6BBRCA2BRCA2OBSCNOBSCNRBBP8RBBP8MAST2MAST2RPS6KA3RPS6KA3RAB33BRAB33BAPAF1APAF1AG120AG120IDH1IDH1TemozolomideTemozolomideATMATMBevacizumabBevacizumabErlotinibErlotinibNF1NF1CCDC6CCDC6ADAM29ADAM29BCL11BBCL11BNOTCH4NOTCH4WLSWLSRANBP17RANBP17MGAMGASMAD3SMAD3QS-11QS-11PPM1EPPM1EGefitnibGefitnibSarcolysinSarcolysinKRASKRASDICER1DICER1RIOK1RIOK1BAY.61.3606BAY.61.3606OSU-03012OSU-03012AC1NS4S0AC1NS4S0CREB1CREB1MYLKMYLKFANCFFANCFCARD10CARD10FERFERWNK1WNK1SMAD1SMAD1TRIM36TRIM36MAPK4MAPK4CLSTN1CLSTN1LPPLPPFLT4FLT4KNL1KNL1PHKG2PHKG2PTK7PTK7MAP3K14MAP3K14LY3023414LY3023414GSK2636771GSK2636771AZD8186AZD8186GSK690693GSK690693PTENPTENDLL4DLL4CASP8CASP8FLNCFLNCYAP1YAP1SGK3SGK3SMARCB1SMARCB1SCYL3SCYL3ARHGAP9ARHGAP9PRKCEPRKCEMAPKAPK3MAPKAPK3CUBNCUBNMAPK3MAPK3MSH2MSH2BCL9BCL9ZNF668ZNF668NOVA1NOVA1FLI1FLI1TRIOTRIOGLI1GLI1BRSK2BRSK2MYH11MYH11GTSE1GTSE1PPARGPPARGTTKTTKSMARCA4SMARCA4CHL1CHL1DYRK1ADYRK1AROBO1ROBO1USP6USP6TSHRTSHRLRRK2LRRK2RNASELRNASELNEK1NEK1UBE2OUBE2OEPHA8EPHA8ABCA3ABCA3CHEK1CHEK1steroids in early settingsteroids in early settingRo4929097Ro4929097Pf-03084014Pf-03084014Gamma secretase inhibitorsGamma secretase inhibitorsMk-0752Mk-0752NOTCH1NOTCH1FURINFURINATP8B1ATP8B1IL1RNIL1RNPPARDPPARDCSF3CSF3HAPLN1HAPLN1GRAMD1BGRAMD1BDCLK3DCLK3ROBO2ROBO2FGFR inhibitorsFGFR inhibitorsFGFR3FGFR3MDM4MDM4SMAD2SMAD2FANCIFANCIMINK1MINK1ACVR2AACVR2AGRIN2BGRIN2BVDAC1VDAC1PLK3PLK3PD-173074PD-173074InfigratinibInfigratinibFGFR1FGFR1SLC45A2SLC45A2TNFSF11TNFSF11PTK2PTK2UBR5UBR5ADHFE1ADHFE1NIM1KNIM1KCNOT6CNOT6Dovitinib Dilactic Acid (TKI258 Dilactic Acid)Dovitinib Dilactic Acid (TKI258 Dilactic Acid)FGFR2FGFR2MERTKMERTKMYLK2MYLK2KALRNKALRNPIK3C2APIK3C2AGOLGA8BGOLGA8Bisoevodiamineisoevodiamine

Models in Isoevodiamine

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​